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No mechanistic link has tied inflammation to suppression of feed intake. In 
rodents, an acute phase protein, α-1-acid glycoprotein (AGP), could provide this link by 
acting as a leptin receptor agonist. The objective of these studies was to determine the 
effects of AGP on food intake and rectal temperature in sheep. In the first experiment 
ewes (n=4) received 1 of 4 treatments [0 (control), 0.012 (low), 0.06 (medium), or 0.30 
(high) mg / kg BW AGP] into the lateral ventricle. The study was repeated until all sheep 
received all treatments. In the second experiment ewes (n=10) received one of two 
treatments (0 and 3 mg / kg BW of AGP) intravenously. In the third experiment ewes (n 
= 19) received peripheral treatments (IV) of an antipyretic [0 (control) or 2.2 mg / kg BW 
flunixin meglumine] 30 minutes prior to receiving central treatments (ICV) [0 (control) 
or 0.3 mg / kg BW AGP]. In the first experiment there was no effect of treatment on feed 
intake rate (P = 0.37) or cumulative feed intake (P = 0.31). There was an effect of 
treatment on rectal temperature (P = 0.002) such that rectal temperatures were greater (P 
< 0.05) following the high dose of AGP. In the second experiment there was no effect of 
treatment on feed intake rate (P = 0.98), on cumulative feed intake (P = 0.41) or on rectal 
temperature (P = 0.71). In the third experiment there was an effect of central treatment (P 
< 0.0001) and an interaction of central treatment and time (P < 0.0001). There was no 
effect of peripheral treatments (P = 0.93) on rectal temperature, indicating that central 
AGP may increase rectal temperature in sheep by pathways that do not involve 
prostaglandins. Further research is needed to determine if AGP may be an important 
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Systemic inflammation is common in the first week of lactation. Inflammation is 
the host protective response to pathogenic (e.g., infection or non-pathogenic (e.g., stress)) 
damaging stimuli. Recently, Bradford and others (2015) highlighted the major differences 
between acute and sub-acute/metabolic inflammation in dairy cows. Briefly, 
inflammatory molecules promote increased blood flow to the infected tissue, immune cell 
infiltration and activation, and systemic responses, including increased body temperature, 
increased heart rate, and decreased feed intake. In contrast, “metabolic inflammation” is 
characterized by its sub-acute, chronic nature and subtle shifts in both immune cell and 
metabolic function. The presence of an inflammatory state in the postpartum period has 
been documented in a number of species, including cattle (Humblet et al., 2006, Mullins 
et al., 2012), mice (Gregor et al., 2013), pigs (Rosenbaum et al., 2012a, b), and humans 
(Disilvestro, 1986). Unlike inflammation associated with a local infection, the postpartum 
inflammatory state has no clear focal organ and does not necessarily induce the 
traditional signs of inflammation (fever, swelling, pain). Rather, inflammation during this 
period is systemic and sub-acute, consistent with the concept of metabolic inflammation. 
Although data are limited, mammary (Clarkson et al., 2004), liver (Loor et al., 2005), and 
adipose (Sadri et al., 2010, Gregor et al., 2013) tissue all show increased inflammatory 
signals in early lactation, and other metabolic organs are also likely affected.  
One effect of cytokines is to activate production of acute phase proteins. Primarily 




reactive protein, and alpha-1-acid glycoprotein (AGP). Proteins that participate in the 
acute phase response to infection are generally found in very low abundance in the 
bloodstream, but are greatly elevated during periods of systemic inflammation. The 
presence of an acute phase response in postpartum dairy cows is well established. 
Numerous studies in the past decade have demonstrated that inflammatory and acute 
phase mediators are elevated in the days after parturition, even in cows that are 
apparently healthy (Humblet et al., 2006, Bionaz et al., 2007, Huzzey et al., 2009, 
Graugnard et al., 2012, Mullins et al., 2012, Qu et al., 2014). This growing body of 
evidence suggests that either the processes of parturition and galactopoiesis induce 
inflammation directly or that infections or endotoxin affect far more postpartum cows 
than is currently recognized. Whatever the explanation, the prevalence of postpartum 
inflammation raises important questions about the implications of this inflammation on 
central regulation of feed intake.  
Greater degrees of inflammation are associated with poor performance. Although 
most transition dairy cows apparently go through a period of inflammation, the 
magnitude of this inflammatory condition varies greatly between cows. Bertoni et al. 
(2008) assessed the importance of this variation by measuring a panel of inflammatory 
markers and separating transition cows into quartiles for degree of inflammation. Cows in 
the highest quartile had significantly lower milk yields, greater proportions of cows with 
health problems, and lower conception rates. One metric that has been used in this respect 
is paraoxanase, a plasma biomarker that is potently suppressed by a variety of 




to having lower concentrations of acute phase proteins and reactive oxygen metabolites, 
produced more milk, and had lower proportion of cows reporting at least one health 
problem (Bionaz et al., 2007). Because haptoglobin is the acute phase protein reaching 
the highest concentration in response to inflammation in ruminants, it has been widely 
used as an inflammatory marker. Recently, a greater magnitude of inflammatory 
response, measured in terms of circulating haptoglobin, during the transition period was 
associated with an impaired performance (Huzzey et al., 2015). Increments of 1 g/L of 
haptoglobin at -2, -1 and +1 weeks relative to parturition reduced whole-lactation milk 
yield by ~ 500 kg. Furthermore, increase of postpartum haptoglobin was negatively 
associated with hazard of conception (0.70 – 0.97, 95% coefficient interval). More 
recently (McCarthy et al., 2016), cows were categorized in 4 quartiles of inflammation 
based on plasma haptoglobin concentration during the first week postpartum. 
Interestingly, cows in Q2 and Q3 (moderate inflammation) had lower dry matter intake 
and BW postpartum, coupled with tendency for lower fat- and energy-corrected milk. 
These longitudinal studies strengthen the established links between postpartum 
inflammation and negative health and production outcomes. Additionally, incidence of 
diseases such as metritis, mastitis, and others have been evaluated using, the acute phase 
protein, AGP as a potential marker for disease incidence (Tamura et al., 1989, Eckersall 
et al., 2001, Sheldon et al., 2001, Cairoli et al., 2006), albeit using a more limited number 
of cows (n = 10 to 90) as compared with studies with haptoglobin cited above (n = 67 to 
412). The limitation of associative data is that its interpretation is difficult because it does 




primary inflammatory conditions that impaired feed intake and overall performance, it is 
also possible that impaired intake exacerbates inflammation, impairing health and 
productivity. To carefully determine whether inflammation or intake is the primary cause 
of peripartum disorders, more controlled studies are required.  
Feed Intake 
In spite of the great body of research in dairy cattle and many other species to 
identify the role of inflammatory and acute phase mediators on metabolic function, little 
research has focused on studying their role in feed intake regulation. Feed intake 
regulation is a complex phenomenon integrating peripheral and central signals in the 
hypothalamus. Regulation of feed intake has been a focus of research for many years. In 
ruminants, attempts to develop models for intake prediction are mostly focused on 
physical and chemical factors (Ingvartsen and Andersen, 2000). Forbes extensively 
studied physical regulation of intake and attempted to study its interaction with metabolic 
regulators and neuronal signaling (Forbes, 1980, 1996). Studies across many decades 
have identified numerous metabolic compounds and hormones that influence 
hypothalamic signals of satiety or hunger (Ingvartsen and Andersen, 2000, Allen and 
Piantoni, 2013). The physiological mediators of metabolite responses are complex and 
diverse; among several proposed mechanisms of peripheral regulation of intake, the 
hepatic oxidation theory appears to be the best suited for ruminants accounting for 
differences in fuels absorbed and sites of absorption (Allen et al., 2009, Allen and 




Marked depression in feed intake is common during the peripartum period. After 
17 years and despite of the great body of research we still are unable to answer a key 
question formulated by Drackley (1999): “what controls dry matter intake during the 
transition period?” Variability in feed intake during the first week postpartum is 30 to 
40%, whereas DMI variation after peak lactation is only 6 to 10% (Drackley, 1999). 
Dairy cows at parturition face a drastic increase in nutrient requirements (2 to 4x for 
many nutrients) driven by the increased demands for milk production, which are 
compensated by increases in hepatic gluconeogenesis and mobilization of body stores of 
fat, protein, and calcium (Roche et al., 2013). Dry matter intake during the first week of 
lactation only increases by 30 to 50%, and if this increase is delayed, it forces the cow to 
mobilize excessive amount of body reserves, exacerbating the risk of metabolic disorders 
and disease development (Ingvartsen et al., 2003). Inflammation during the first week of 
lactation is associated with depressed feed intake in dairy cows (Bertoni et al., 2008, 
McCarthy et al., 2016). 
Although no associations of intake and AGP have been reported for ruminants, a 
study involving dairy cows, Jafari et al. (2006), evaluated the infusion of three levels of 
glutamine on dry matter intake and plasma concentrations of AGP in transition cows. 
Using data from that study, a negative association was found between dry matter intake 
adaptation to lactation and the rise in plasma AGP after parturition. Using mean values 
for dry matter intake and AGP for days 7 to 21 (n = 9), it was found that AGP was 





Fever, known by an elevated body temperature, is well known in response to 
inflammation or infections. Many exogenous pyrogens (ex: lipopolysaccharide; LPS) can 
cause a fever. The presence of these substances induce the production of proteins called 
cytokines. Cytokines such as, tumor necrosis factor alpha (TNF-α) and other interleukins, 
have been found in circulation (Kluger, 1991, Jansky et al., 1995), however changes in 
interleukin-6 concentrations in the rat best match the change in temperature produced by 
administration of LPS (Lemay et al., 1990). Cytokines have various routes to access the 
brain. Described in a review by Blomqvist and Engblom (2018) are four routes used to 
bypass the blood-brain-barrier and get the signals to the brain. Thermosensitive neurons 
in the hypothalamus are exposed to cytokines at the onset of a temperature. Researchers 
found that administering endogenous pyrogens released fever inducing prostaglandins 
(Feldberg and Saxena, 1971). Soon thereafter, Vane (1971) administered the antipyretic 
drug, aspirin, for prostaglandin inhibition and decreased the induced fever.  
LEPTIN 
Introduction 
One of the most important endocrine factors is leptin, a cytokine-like hormone 
produced by adipose tissue. Leptin, known for its homeostatic regulation of adiposity, is 
one of the main contributors in energy homeostasis, proving that obesity can be a sign of 
resistance to its role (Ahima and Flier, 2000, Munzberg and Myers, 2005). Leptin exerts 




(LepRb) in the hypothalamus. There are six isoforms of the leptin receptor, among those, 
LepRb is the only isoform with capacity to transmit leptin signaling and initiate the 
signaling response (Kwon et al., 2016). Neurons located in the hypothalamus monitor 
energy status by sensing concentrations of hormones (e.g., leptin; (Ingvartsen and 
Boisclair, 2001)) and nutrients (e.g., free fatty acids; (Obici et al., 2002)). 
Leptin Background 
The concept began with the discovery of two recessive mutations in mice, obese 
(ob) and diabetes (db), with the effects of hyperphagia, decreased energy expenditure, 
and early onset obesity (Ingalls et al., 1950). The joining of two mice, known as 
parabiosis, showed that when a normal wild-type mouse was joined with an ob/ob mouse, 
the obese model mouse began to lose weight (Hausberger, 1958). However, parabiosis of 
the db/db model found the wild-type mouse suffering from hypophagia (Coleman and 
Hummel, 1969, Coleman, 1973). This information led to the discovery of their role: the 
ob gene product was named leptin (from the Greek root, leptos, which translates meaning 
thin) because of its effects on leptin-deficient and normal mice (Halaas et al., 1995).  The 
db locus is needed for response to the satiety factor. 
Leptin Pathway in the Brain 
For leptin, several signaling pathways can mediate the hypothalamic actions, with 
most effects thought to be via the JAK/STAT signaling pathway. After leptin binds to 
LepRb, downstream signaling through the sequential phosphorylation of the tyrosine 




transcription (STAT) is initiated. Phosphorylated STAT3 is translocated to the nucleus 
where it modulates the transcription of genes involved in feed intake, resulting in altered 
neuropeptide production and release (Vaisse et al., 1996). Leptin increases the 
transcription of proopiomelanocortin (POMC) which in turn stimulates the synthesis of α-
melanocyte stimulating hormone (α-MSH), which exerts its anorexigenic (intake 
inhibition) effect by binding to the melanocortin-4 receptor (MC4R) in the hypothalamus 
(Ellacott and Cone, 2004). Additionally, leptin inhibits the neuronal activity of agouti-
related protein (AgRP) and reduces the expression of neuropeptide Y (NPY) and AgRP, 
both orexigenic (intake-promoting) neuropeptides. The net effect of leptin signaling is 
therefore a decrease in feed intake (Myers et al., 2008). 
Leptin in Rodents 
 With the center of leptin research established in the rodent model, the 
mechanisms and purpose of this hormone are fairly clear. However, further research 
continuously discovers more about it. There are both central and peripheral mechanisms 
that control leptin’s effect on food intake and energy expenditure. Leptin receptors are 
expressed in most tissues of the rodent. In rodent models, mutations in the leptin and 
leptin receptor genes can result in morbid obesity, infertility, and insulin resistance (Chua 
et al., 1996, White et al., 1997, Farooqi, 2002, Perry et al., 2014). It has been determined 
that administration of central leptin in rats increases body temperature (Luheshi et al., 
1999, Turek et al., 2004, Skibicka and Grill, 2009). As with inflammatory studies in the 




was able to block the leptin-induced temperature via the prostaglandin pathway. More 
recently, researchers are using leptin, in a diabetic model, to find a mechanism that will 
help diminish type I diabetes (Kadota et al., 2018). 
Leptin in Ruminants 
 Leptin properties in the ruminant model has shown similar results as human and 
rodent research (Chilliard et al., 2001). For example, ovine leptin given centrally to goats 
and sheep was found to reduce food intake (Clarke et al., 2001). Plasma leptin is higher 
in sheep and cows with higher body fatness (Blache et al., 2000, Delavaud et al., 2000). 
These few examples in ruminant species are parallel with those in mice and humans. 
However, the factor that sets them apart is the discovery of leptin levels, unlike in non-
ruminant studies, does not increase in response to inflammatory indicators. Rodent 
studies have shown that administration of LPS peripherally causes an increase of plasma 
leptin levels, suggesting a role of leptin in anorexia induced by endotoxin (Francis et al., 
2000). In sheep, however, peripheral administration of LPS had no effect on plasma 
leptin concentrations but sheep still showed signs of anorexia and fever (Soliman et al., 
2001)). Soliman and others (2002) then continued by replicating this experiment in cattle. 
The plasma leptin concentrations from these cows were not changed for 8 hours, showing 
almost the same concentration as those in saline-injected controls. These discoveries 
suggest that leptin may not be involved in anorexia and fever in ruminants with 







Alpha-1-acid-glycoprotein, (AGP) also known as orosomucoid, is a versatile 
acute phase protein with diverse roles.  From rodent studies, it is now known that AGP 
exerts some anti-inflammatory and immunomodulatory properties (Hochepied et al., 
2003). More recently, AGP has been identified as a protein capable of integrating 
inflammatory and metabolic signals to modulate immune responses, protecting adipose 
tissue from excessive inflammation by improving glucose and insulin tolerance in mice 
(Lee et al., 2010). It has also been reported that AGP was consistently found in high 
concentrations around parturition, and has been associated with greater incidence of 
several diseases in cattle (Tamura et al., 1989, Eckersall et al., 2001, Sheldon et al., 2001, 
Cairoli et al., 2006). In the early 1990’s a new role for AGP was discovered by 
serendipity when Bellinger et al. (1990) were investigating the purity of extracted 
satietin, a putative hypophagic endocrine factor in plasma. Bellinger and coworkers 
found that the extracted satietin was contaminated with other plasma proteins (e.g., 
albumin and AGP). After further purification and isolation, they determined that centrally 
administered purified AGP was also able to induce hypophagia in rodents.  
Alpha-1-acid-glycoprotein in the Leptin Pathway 
Since the early 1990’s, the putative role of AGP was not evaluated further until a 
recently published paper in Diabetes (Sun et al., 2016) thoroughly documented the role of 




feed intake. Sun and Coworkers (2016) fed C57BL/6 or db/db mice with a normal diet. 
Feed intake was reduced in C57BL/6 mice but not in db/db in response to intraperitoneal 
infusions of AGP for four consecutive days. The lack of hypophagic effect of AGP in 
db/db mice led authors to hypothesize that AGP signals via LepR. Subsequently, they 
silenced LepR in the hypothalamus of C57BL/6 mice and demonstrated that the 
hypophagic effects of AGP were blocked.  
This discovery immediately found ruminant researchers discussing the possibility 
of AGP playing a role in hypophagia of cattle under inflammatory conditions. The 
Bradford group has been investigating the systemic effects of inflammation during the 
immediate postpartum period in cattle (Bradford et al., 2015). To mimic systemic 
inflammation, the Bradford group subcutaneously administered recombinant TNFα to 33 
transition cows assigned to control (carrier), low dose (1.5 μg/kg BW), or high dose (3.0 
μg/kg) daily from day 1 to 7 of lactation (Yuan et al., 2013). This treatment protocol 
performed did not induce pyrexia or other acute responses because the subcutaneous 
route of administration slowed the appearance of the protein in circulation. The mild 
elevation in plasma TNFα nevertheless induced an increase in plasma haptoglobin and 
had a dramatic impact on dry matter intake and milk production by significantly 
decreasing dry matter intake and milk yield throughout the first week of lactation. 
Bradford et al. (2015) results were inconsistent with the hypothesis that inflammation in 
early lactation primarily influenced liver function; rather, inflammation during this period 





In summary, if AGP acts as a LepRb agonist in ruminants, as reported in mice 
(Sun et al., 2016), it’s increase during peripartum inflammation may be the link between 
inflammation and hypophagia that is a common precursor to common metabolic and 
infectious disorders in early lactation dairy cows. Research regarding the possibilities of 
alpha-1-acid-glycoprotein in inflammatory models is ongoing. This should give a greater 
insight to the many diverse roles that leptin and its receptor play in the ruminant model, 















EFFECTS OF CENTRAL AND PERIPHERAL ADMINISTRATION 
OF AN ACUTE PHASE PROTEIN, ΑLPHA-1-ACID-
GLYCOPROTEIN, ON FEED INTAKE AND RECTAL 



















 In rodents, an acute phase protein, α-1-acid glycoprotein (AGP), could provide 
this link by acting as a leptin receptor agonist. Serum concentrations of AGP rise 
markedly during inflammation. The objective of this study was to determine the effects of 
AGP on feed intake and rectal temperature in sheep. Ewes were ovariectomized, 
implanted with a cannula into a lateral ventricle of the brain, and kept indoors in 
individual pens. Feed intake and rectal temperature was determined for sheep in all 
experiments. In the first experiment ewes (n = 4) received one of four treatments [0 
(control), 0.012 (low), 0.06 (medium), or 0.30 (high) mg / kg BW AGP] into the lateral 
ventricle. The study was repeated until all sheep received all treatments. In the second 
experiment ewes (n = 10) received one of two treatments (0 and 3 mg / kg BW of AGP) 
intravenously. In the third experiment ewes (n = 19) received peripheral treatments (IV) 
of an antipyretic [0 (control) or 2.2 mg / kg BW flunixin meglumine (FLU)] 30 minutes 
prior to receiving central AGP [0 (control) or 0.3 mg / kg BW of AGP]. All data were 
analyzed using a mixed model analysis of variance, SAS software v9.4 (SAS Institute 
Inc., Cary, NC), and tested for effects of treatment, time, and the interaction of treatment 
and time. Cumulative feed intake following administration of treatments was tested for 
effects of treatment. In the first experiment there was no effect of treatment (P = 0.37) on 
feed intake rate and no effect of treatment (P = 0.31) on cumulative feed intake. There 
was an effect of treatment (P = 0.002) on rectal temperature such that rectal temperatures 
were greater (P < 0.05) following the high dose of centrally administered AGP. In the 




cumulative feed intake (P = 0.41) or on rectal temperature (P = 0.71). In the third 
experiment there was an effect of central treatment (P < 0.0001) and an interaction of 
central treatment and time (P < 0.0001) on rectal temperature such that ewes treated 
centrally with AGP had greater rectal temperatures. There was no effect of peripheral 
treatments (P = 0.93) on rectal temperature. These results indicate that central AGP 
increases rectal temperature in sheep by pathways that do not involve prostaglandins. 
Further research is needed to determine if AGP may be an important integrator of energy 















 Both inflammation and sub-optimal feed intake are common in livestock during 
the transition from late gestation to lactation, and both conditions are associated with 
greater risk for removal from the herd and less productivity (Bradford et al., 2015). Along 
with decreased feed intake, fever is also associated with inflammation (Ingvartsen and 
Andersen, 2000, Sartin et al., 2008). 
Leptin, an adipokine synthesized and released into circulation in proportion to the 
amount of body fat, plays a crucial role in the regulation of food intake and energy 
expenditure (Elmquist et al., 1998, Friedman and Halaas, 1998, Ahima and Flier, 2000, 
Blache et al., 2000, Delavaud et al., 2000, Ehrhardt et al., 2000). Administration of leptin 
reduces food intake, increases energy expenditure and body temperature (Halaas et al., 
1995, Barb et al., 1998, Henry et al., 1999, Morrison et al., 2001, Henry et al., 2008, 
Skibicka and Grill, 2009, Henry et al., 2011). In rodents and primates leptin gene 
expression in adipocytes and/or circulating concentrations of leptin are increased by 
bacterial endotoxin and pro-inflammatory cytokines such as tumor necrosis factor-ɑ and 
interleukin-1β (Grunfeld et al., 1996, Finck et al., 1998, Francis et al., 1999, Landman et 
al., 2003). Therefore, leptin is an important hormone regulating food intake, metabolism, 
and body temperature in sick animals (Harden et al., 2006). 
Although leptin regulates food intake (Chilliard et al., 2005) and endocrine events 
in ruminants (Morrison et al., 2001, Daniel et al., 2002, Zieba et al., 2005), plasma leptin 
in ruminants is unchanged by endotoxin/inflammation (lipopolysaccharide, LPS) 




the mechanisms by which inflammation and/or endotoxin (lipopolysaccharide; LPS)  
induces changes in food intake, metabolism, and body temperature in domestic species, 
like sheep and cattle. One response of animals to inflammation and models of 
inflammation (endotoxin administration) is the synthesis and secretion of acute phase 
proteins into circulation. These proteins are generally produced by the liver and normally 
are found in low abundance in the bloodstream, but are greatly elevated during periods of 
systemic inflammation (Murata et al., 2004, Petersen et al., 2004). Alpha-1-acid 
glycoprotein (AGP) is an acute phase protein with diverse roles. In rodents, AGP has 
anti-inflammatory and immunomodulatory properties (Hochepied et al., 2003). Bellinger 
and co-workers determined that central administration of AGP induced hypophagia in 
rodents (Bellinger and Mendel, 1990). The putative role of AGP was not evaluated 
further until a recent publication (Sun et al., 2016) thoroughly demonstrated the role of 
AGP as a hypophagic compound, signaling via the hypothalamic leptin receptor (LepR) 
to reduce feed intake in rodents. While these findings are interesting, it is exciting to 
consider the potential role of AGP as a link between inflammation, appetite, and 
temperature regulation in ruminants, as they lack the typical inflammation-induced leptin 
response observed in rodents and humans. Therefore, AGP may play an even more 
important role in the effects of inflammation on appetite and temperature regulation in 
ruminants than other species. The objectives of this study were to determine the effects of 
central and peripheral AGP administration on feed intake and rectal temperature in sheep 





MATERIALS AND METHODS 
 The Institutional Animal Care and Use Committee of the University of Tennessee 
approved, in protocol number 2514-0217, all procedures and protocols used throughout 
this experiment.  
Animals and Maintenance 
Non-lactating, non-pregnant mature (≥1 yr of age) Suffolk or Suffolk-cross 
female sheep were ovariectomized to avoid cyclic variations in plasma concentrations of 
steroids that may affect feed intake (Laker et al., 2011).Animals were allowed at least 2 
weeks for recovery before subsequent surgeries and at least 1 month before used in any 
experiments. Each sheep was then fitted with an intracerebroventricular (ICV) catheter 
into a lateral ventricle of the brain as previously described (Whitlock et al., 2010). Twice 
each week during the entire duration of the ICV catheter presence, antibiotics were 
administered in order to prevent potential infections and help maintain catheter patency. 
Catheter patency was assessed each time antibiotics were administered centrally by 
attempting to withdraw approximately 1 mL of cerebrospinal fluid (CSF) from the 
subcutaneous port and ICV catheter unit. The ICV antibiotic “cocktail” included 
Gentamycina (40 mg / mL) and Vancomycina HCl (equivalent to 500 mg of 
Vancomycin). Approximately 100 µL of the antibiotic cocktail [Gentamycin (5 mg / mL) 
and Vancomycin (10 mg / mL)] was administered through the port and ICV catheter and 
subsequently flushed with approximately 250 µL of sterile, nonpyrogenic, isotonic, 0.9% 
sodium chloridea. Based upon previous experience, at least 80% of the ICV catheters and 




therefore additional animals were prepared in anticipation of a failure rate of no more 
than 20%. For all ICV injections, the skin above the port site was aseptically prepared 
with 70% isopropyl alcohol prior to all central treatment and treatments were 
administered through the skin and into the port via a 25-gauge Huber Point needleb 
followed with 250 µl of sterile 0.9% salinea to flush the port and catheter. Ewes were kept 
indoors in individual pens (approximately 3 m2) with an environment consisting of a 12-
hour light/dark photoperiod and approximately 22-24℃. Ewes were fed a diet (Table 1) 
calculated to meet 100% of daily maintenance requirements (NRC, 1989) and had ad 
libitum water.  
Experiment 1- Effects of Central Administration of α-1-acid-glycoprotein on Feed 
Intake and Rectal Temperature in Sheep 
Ovariectomized sheep (n = 4) weighing 79.0 ± 5.0 (SD) kg, with patent ICV 
catheters and ports, received 1 of 4 treatments [0 (control), 0.012 (low), 0.060 (medium), 
or 0.30 (high) mg / kg BW AGP (AGP from bovine plasma)c] administered in 500 µL of 
sterile, nonpyrogenic, isotonic, 0.9% sodium chloridea into the lateral ventricle. The day 
before each experimental period body weights were determined. A 10-d interval was 
allowed between experimental periods and each period lasted 5 days, with 3 days for 
basal measure of feed intake and rectal temperature and 2 days for measurement of feed 
intake and rectal temperature after experimental treatment administration. Experimental 
treatments were administered as a single bolus reconstituted in 500 μL of pyrogen-free 
salinea (Daniel et al., 2016). Feed intake and rectal temperature were determined at -72, -




the respective treatments). The study was repeated until all sheep received all treatments 
with a 10-d washout period between treatments.  
Experiment 2- Effects of Peripheral Administration of α-1-acid-glycoprotein on Feed 
Intake and Rectal Temperature in Sheep 
Ewes (n = 10) weighing 78.5 ± 23.7 (SD) kg were randomly assigned to two 
treatments (0 and 3.0 mg / kg BW of AGPc). Approximately 24 hours prior to treatment 
administration, sheep body weights were determined and the area over each animal’s 
jugular vein was desensitized by SC administration of 2% lidocaine hydrochloride 
solutiond prior to inserting a cathetere into the vein. The catheter was attached to an 
extension setf and then sutured to the ewe’s neck. The catheters and extension sets were 
flushed with heparinized saline (0.9% sodium chloride) solution (20 U of heparin / mL). 
Each ewe was infused via IV catheters with one of 2 doses (0 or 3.0 mg / kg BW) of a 
commercially available AGP extracted from bovine plasmac. The dose of AGP was 
selected based on the greatest dose administered centrally in experiment one (0.30 mg / 
kg BW). The dose administered IV in this experiment was approximately 10-fold greater 
than the greatest dose administered centrally in experiment one. Using a 10-fold greater 
dose has been utilized in previous experiments when going from central to peripheral 
treatment administration (Whitlock et al., 2010). AGP was administered as a single bolus 
reconstituted in approximately 1 mL of pyrogen-free salinea (Daniel et al., 2016). The 
sheep were offered a known amount of fresh feed ad libitum. Feed was weighed and 
replaced with fresh feed and rectal temperatures were determined at -72, -48, -24, 0, 2, 4, 




Following a washout period ≥10 days, sheep were included in subsequent 
experimentations (Experiment 3). 
Experiment 3- Effects of Peripheral Administration of a Non-Steroidal Anti-
Inflammatory, Flunixin Meglumine, and Central Administration of α-1-acid-
glycoprotein on Feed Intake and Rectal Temperature in Sheep 
 Ewes (n = 19; weighing 85.4 ± 19.4 kg) previously ovariectomized and implanted 
with an ICV catheter and port were used in this experiment. Approximately 24 hours 
prior to treatment administration, body weights were determined and jugular catheterse 
were inserted and maintained (as described previously in experiment 2). Sheep were 
assigned to receive peripheral treatments [administered IV; 0 (SALa; equal volume of 
SAL to match the other IV treatment) or 2.2 mg / kg BW flunixin meglumine (FLUg; a 
cyclooxygenase inhibitory non-steroidal anti-inflammatory drug)] 30 minutes prior to 
receiving centrally [administered ICV through a port and catheter into the lateral ventricle 
of the brain; 500 uL of SALa or 25 mg AGPc (approximately 0.3 µg / kg BW) 
administered in 500 µL of sterile, nonpyrogenic, isotonic, 0.9% sodium chloridea]. Feed 
intake and rectal temperature was determined at -48, -24, -2, 0, 2, 4, 6, 8, 12, and 24 h 
relative to AGP treatment (time 0: administration of the AGP treatments). 
Statistical Analysis 
To determine the effects on food intake rate and rectal temperature throughout the 
experiments, data were analyzed using the GLIMMIX procedure for mixed model 
analysis of varianceh and tested for fixed effects of treatment, time, and their interactions. 




of treatment using the GLIMMIX procedure for mixed model analysis of varianceh. 
Values of P < 0.05 were considered significant. 
RESULTS 
Experiment 1 
 Central administration of AGP did not affect rate of feed intake (P = 0.37; Figure 
1) or 48-hour cumulative feed intake (P = 0.31; Figure 2). There was an effect of time (P 
< 0.0001) but no interaction of central treatment and time (P = 0.97) on feed intake rate. 
Central administration of AGP increased rectal temperature (P = 0.002) and maximum 
rectal temperatures in the high dose AGP group were approximately one degree greater 
compared to controls at eight hours, the time at which rectal temperatures reached their 
peak, and were greater (P < 0.05) following administration of the high dose compared to 
all other doses administered (Figure 3). There was an effect of time (P < 0.001) on rectal 
temperature and there was a tendency for an interaction of treatment and time (P = 0.07). 
Experiment 2  
 Peripheral administration of AGP did not affect rate of feed intake (P = 0.98; 
Figure 4) or 48-hour cumulative feed intake (P = 0.41; Figure 5). There was an effect of 
time (P = 0.004) but no interaction of peripheral treatment and time (P =0.77) on feed 
intake rate. Unlike central AGP, peripheral administration of AGP did not increase rectal 
temperature (P = 0.71; Figure 6). There was no effect of time (P = 0.10) or an interaction 







 Central administration of AGP did not affect rate of feed intake (P = 0.18; Figure 
7) or 24-hour cumulative feed intake (P = 0.79; Figure 8). There was no effect of time (P 
= 0.28) or an interaction of central treatment and time (P = 0.64). Moreover, peripheral 
administration of AGP did not affect rate of feed intake (P = 0.88; Figure 7) or 24-hour 
cumulative feed intake (P = 0.92; Figure 8). The interaction of peripheral treatment and 
time (P = 0.21), peripheral by central treatment (P = 0.42), or peripheral by central 
treatment by time interaction (P= 0.50) did not affect feed intake rate. The interaction of 
peripheral and central treatments did not affect 24-hour cumulative feed intake (P = 
0.32). 
Although feed intake was not affected, central administration of AGP increased 
rectal temperature (P < 0.0001). There was an effect of time (P < 0.001) and an 
interaction of central AGP administration and time (P < 0.0001) on rectal temperature, 
such that rectal temperatures in the AGP group were greater than controls (P < 0.05) at 2, 
4, 6, 8, and 12 hours following central treatment administration (Figure 9). Peripheral 
flunixin meglumine administration had no effect (P = 0.93) on rectal temperatures. 
Moreover, there was no interaction of peripheral treatment and time (P = 0.35), peripheral 
and central treatment (P = 0.54), or peripheral, central treatment and time (P= 0.15) on 
rectal temperature. 
DISCUSSION 
 Identifying the direct causes of intake depression is critical to preventing a 




coworkers clearly demonstrated in rodents that AGP could potentially provide a link 
between inflammation and reduced feed intake via the leptin receptor (2016). Our results 
show that AGP can induce an increase in rectal temperature in the ruminant model, 
sheep. Our discovery of an effect of AGP on rectal temperature  was found to not be 
dependent on the prostaglandin pathway. While feed intake rate was not affected by AGP 
administration, 24-hour cumulative feed intake was numerically greater, although not 
significant,  following the highest dose of centrally administered AGP. 
Feed Intake 
 It is well-documented that during the transition period dairy cows undergo a 
marked systemic inflammation accompanied by an array of responses, some of which 
may be adaptive and others pathological. One of the most dramatic responses putatively 
tied to exaggerated peripartum inflammation is suppressed feed intake, but the 
mechanisms that underlie this relationship are poorly understood.  
The acute phase protein AGP is elevated in early lactation in cattle (Cairoli et al., 
2006). A recent study in mice demonstrated that AGP has potent hypophagic effects (Sun 
et al., 2016). Therefore, AGP is a candidate for inflammation-induced suppression of 
food intake in ruminants. Interestingly, while AGP suppressed feed intake in ob/ob, mice 
it had no effect on feed intake in db/db mice (Sun et al., 2016) leading the authors to 
speculate that the effects of AGP on feed intake were mediated through the LepR. Sun et 
al. (2016) confirmed their speculation when administration of AGP failed to affect feed 
intake in mice with temporarily silenced LepR. Further, they ultimately demonstrated 




In our first study, while numerically the greatest dose of AGP centrally 
administered to sheep had the least cumulative food intake 48 hours later, the effect of 
AGP on feed intake was not significant. Potentially the central route of AGP 
administration has no effect or less effect on feed intake. However, it was observed 
previously that central administration of AGP decreased feed intake in rats (Bellinger and 
Mendel, 1990). While studying the effects of satietin on feed intake in rats, Bellinger and 
Mendel inadvertently administered AGP. Ultimately they determined that the satietin 
they were administering contained albumin and AGP, and when AGP alone was 
administered centrally to rats, food intake decreased (Bellinger and Mendel, 1990). 
Therefore, it is unlikely that the route by which we administered AGP to our sheep in this 
first experiment was the reason feed intake was not significantly decreased. 
Possibly the lack of an effect of centrally administered AGP on feed intake in 
sheep was because the maximum dose given was not sufficient to elicit this response. 
When compared to the dose of AGP administered centrally to rats (50 μg; or 
approximately 0.20 mg / kg BW; (Bellinger and Mendel, 1990)), the maximum dose and 
dose used in experiment one and three of this study, respectively, were greater 
(approximately 25 mg; or approximately 0.30 mg / kg BW). Therefore, the difference in 
response as it relates to feed intake between rats and sheep following central 
administration of AGP cannot simply be explained by differences in doses used. That 
being stated, it is still possible that a greater central dose of AGP is needed to 
suppress/reduce feed intake in ruminants. If AGP truly has a role in inflammation 




possibly in CSF) achieved during systemic inflammation in this species, and necessary to 
affect feed intake, exceed that administered in our model. 
Our original intentions were to administer a greater dose of AGP centrally if there 
was no observed/significant effect of AGP on feed intake in the initial experiment. 
However, subsequent studies of the effects of greater doses of centrally administered 
AGP were not completed because of the unexpected increase in rectal temperature 
following treatment administration. Once we understand better the mechanism(s) by 
which AGP increases rectal temperature in sheep we will likely administer greater doses 
centrally.  
The effects of AGP on feed intake in mice by Sun et al., (2016) were observed 
following peripheral administration (intraperitoneal and IV). Thus, we administered AGP 
peripherally in our second experiment. The dose of AGP used in the second experiment 
(~3.0 mg / kg IV; ~ 250 mg) was 10-fold greater than the greatest dose used in our first 
experiment (~0.30 mg / kg ICV; ~25 mg) to determine if the lack of an effect was 
possibly a result of the route by which the treatments were administered. However, 
similar to the first experiment, AGP had no effect on feed intake in sheep (cumulative or 
feed intake rate). Sun et al. (2016) administered 100 mg / kg IV or ~ 2 mg total to reduce 
feed intake in mice. Based upon their reported body weights, assumed blood volumes, 
and previously reported circulating concentrations of AGP in mice (Kopf et al., 1994), it 
is likely that the 2 mg total dose of AGP administered to the mice increased their plasma 
AGP by approximately 670%. In cattle, serum concentrations of AGP vary. Serum 




increase to ≥ 1000 mg / L during acute inflammation (Ceciliani et al., 2012). Recently we 
observed a negative association between feed intake and serum AGP concentrations in 
periparturient dairy cattle (unpublished). In that study a reduction in periparturient intake 
of feed in dairy cattle was associated with an increase of approximately 40% in plasma 
AGP. While this association does not necessarily confirm causation, it is interesting to 
consider in light of what was previously observed and reported regarding AGP and feed 
intake by Sun and others (2016).  
While there are very few recorded reference ranges for serum concentrations of 
AGP in sheep, a 30 day experiment was conducted with the concentrations of the control 
sheep being approximately 100 mg / L (Eckersall et al., 2007). Concentrations in other 
species (mice, rats, and swine) are similar to those observed/reported in cattle (Pous et al., 
1990, Caperna et al., 2017). Therefore, it is likely that serum concentrations of AGP in 
healthy sheep are not that divergent from other species. Comparatively, if our assumption 
is true, that the normal circulating concentration of AGP in sheep is approximately 300 
mg / L, the IV dose administered to the sheep in this study likely increased their 
(concentration and total) serum AGP by 10 to 13%. If AGP does suppress feed intake in 
ruminants during inflammation, it is possible that the IV dose of AGP administered to our 
sheep was not comparable to increases in serum or plasma normally achieved during 
systemic inflammation associated with suppressed feed intake. Therefore, it is possible 
that a greater IV dose could have an effect on feed intake in sheep. Subsequent analyses 
and validation of AGP assays for serum and plasma of sheep associated with our 




concentrations of AGP in healthy and diseased (inflammation models) animals in this 
species. 
Additionally, bovine AGP includes at least five glycosylations and potentially 
eight phosphorylation sites (Ceciliani et al., 2012). Being similar in humans and rats who 
have six glycosylations (Fournier et al., 2000). Moreover, it is clear that systemic 
inflammation alters AGP glycosylation (Kreisman and Cobb, 2012). Therefore, it is 
possible that there are unique AGP glycosylations associated with inflammation that 
make the AGP molecule respond differently at the site of the LepR. Because of the 
complexity of this protein and changes associated with inflammation, we cannot rule out 
that the observations made during our studies resulted from variation/diversity in 
glycosylation of the AGP administered to our animals. However, we did use the same lot 
of AGP for all studies reported herein. 
Rectal Temperature 
 An unexpected and previously unreported effect of central administration of AGP 
was increased rectal temperature in sheep. While this was a surprising and interesting 
observation, the mechanism(s) by which AGP increased rectal temperature in sheep was 
not immediately clear/obvious. Fever, an elevation in body temperature, may be the result 
of many infectious or inflammatory diseases. To elicit a fever, the infection/inflammatory 
cause triggers cytokine production which then use specific routes crossing the blood-
brain-barrier to initiate a febrile response. A rise in body temperature is necessary in 
many cases for the body to recover from or fight back against the initial foreign cause 




During the first experiment, we observed that central administration of AGP 
increased rectal temperature in sheep. Previous research regarding the effects of AGP on 
feed intake did not determine body temperature; therefore, this is a novel and unexpected 
finding. One potential concern regarding the increased rectal temperature in response to 
central AGP administration was that the administered bovine AGP might have been 
contaminated with endotoxin. To help ensure that the increase temperature in response to 
central AGP was not because of contamination with endotoxin, we determined that our 
AGP did not contain endotoxin using a limulus amebocyte lysate test. Moreover, the 
timing of the increased rectal temperature following central administration of AGP was 
not consistent with previous endotoxin models, in that the increase in temperature was 
later than what would have been observed following endotoxin administration (Kabaroff 
et al., 2006, Feng et al., 2010, Ranjan et al., 2011). Once we confirmed that the AGP did 
not contain endotoxin we turned our attention to other possible mechanisms. 
It has been determined that central leptin administration in rats not only reduced 
feed intake but also increased body temperature (Luheshi et al., 1999, Turek et al., 2004, 
Skibicka and Grill, 2009). If the effect of AGP to suppress food intake in rodents is 
mediated through the LepR as supported by Sun and others (2016), then it is reasonable 
to speculate that AGP, like leptin, could increase body temperature.  It could be that the 
effects of AGP or leptin on body temperature in rodents and/or sheep are more sensitive 
than the effects of either of them on feed intake. However, Luheshi et al. (1999) 
administered various quantities of leptin centrally to rats and found that even their lowest 




temperature. Even given this information, we cannot rule out the possible differences 
between species. We concluded that we should administer AGP by a different route based 
on the previous work in mice. 
 Unlike central, peripheral administration of AGP had no effect on rectal 
temperatures. The peripheral dose of AGP needed to increase rectal temperature may not 
have been achieved. When administering leptin peripherally in rodents, concentrations 
that caused an increase in temperature were 1 mg / rat (~3.5 mg / kg) albeit at a lower 
increase then the central route (Luheshi et al., 1999). Potentially more than a 10-fold 
greater dose, such as a 100-fold greater dose than the central dose would get the same 
results as the central doses. Given that central administration of AGP increased rectal 
temperature in sheep in experiment one, we speculate that the dose given IV in this study 
may not have been sufficient to elicit a response to affect feed intake or rectal 
temperature.  
  While studying the effects of leptin on feed intake and body temperature in rats, 
Luheshi et al. (1999) administered a cyclo-oxygenase inhibitor, flurbiprofen, and found it 
had no effect on feed intake but was able to block the leptin induced increased 
temperature. Therefore, to help elucidate the mechanism(s) by which central 
administration of AGP increases rectal temperature in sheep we designed an experiment 
to eliminate pyrogenic/fever causing pathways that involve prostaglandins. We 
administered flunixin meglumine, a non-steroidal anti-inflammatory drug and potent 
cyclo-oxygenase inhibitor that has antipyrogenic effects involving inhibition of 




Lees and Taylor, 1991). Pretreatment with flunixin meglumine had no effect on increased 
rectal temperature following central administration of AGP. To keep our experimental 
models the same we continued to monitor feed intake and found there was no effect on 
feed intake. Because we observed a tendency to reduce cumulative feed intake 48 hour 
post treatment, we regret not determining/measuring feed intake and rectal temperatures 
out to 48 hours in this subsequent study. We concluded that central AGP administration 
increases rectal temperature in sheep by a mechanism(s) independent of prostaglandin 
synthesis. 
Therefore, it is plausible that central administration of AGP is having an effect on 
body temperature/rectal temperature through actions at the LepR. Moreover, if this effect 
is mediated through the LepR, then it is likely that increased rectal temperature following 
central AGP is affecting the melanocortin system through actions at the LepR to 
ultimately increase body temperature (Turek et al., 2004, Skibicka and Grill, 2009). 
Subsequent studies designed to determine the mechanism(s) by which AGP increases 
rectal temperature in sheep might focus on the effects of blocking hypothalamic 
melanocortin receptors prior to central administration of AGP. 
CONCLUSIONS 
  In summary, although there are many open questions regarding alpha-1-acid 
glycoproteins’ effects on feed intake, we did discover a novel effect on rectal 
temperature. While AGP did not decrease feed intake in our sheep model, central 
administration of AGP did increase rectal temperature in sheep. It has been stated that 




times greater than the normal plasma concentrations of leptin (Luheshi et al., 1999). 
Therefore, it is plausible to assume, if the temperature response was maximal in this 
study, that higher amounts of AGP may decrease feed intake in sheep while not causing 
any greater increase in rectal temperature. Furthermore, administration of flunixin 
meglumine did not abolish the increase rectal temperature brought on by central 
administration of AGP, removing the possibility of prostaglandin pathways involved in 
AGP-stimulated rectal temperature and it would be reasonable to move forward by 
researching AGP actions on the melanocortin pathway in this area. Alpha-1-acid 
glycoprotein may be an important integrator of inflammation, food intake and body 
temperature in ruminants, however, further research is needed to completely elucidate 

















































Inflammation and reduced feed intake are common in dairy cows in the transition 
to lactation, and both conditions are associated with risk for removal from the herd and 
less productivity. Poor feed intake is associated with other negative outcomes detrimental 
to lactation efficiency and the well-being of dairy cows (Grummer, 1995, Huzzey et al., 
2007, Goldhawk et al., 2009). Alpha-1-acid glycoprotein (AGP) has been shown to signal 
via the leptin receptor in rodents to reduce feed intake (Sun et al., 2016). It has been 
discovered that AGP (Cairoli et al., 2006), but not leptin, increases as a result of an 
inflammatory response in ruminants, therefore we hypothesized that AGP may be the 
factor reducing feed intake during the transition period in ruminants. The objectives were 
to test the effects of AGP (1) centrally and (2) peripherally on feed intake and rectal 
temperature then (3) determine the mechanism(s) in which central administration of AGP 
increases rectal temperature. 
In the first experiment, it was hypothesized that central AGP would affect feed 
intake in the ruminant model, sheep. Feed intake was not reduced. This could be because 
of the route of administration although in rodents both central and peripheral routes of 
AGP reduced feed intake so this is unlikely. The greatest dose of AGP had the least 
cumulative food intake 48 hours post treatment, but the effect was not significant. 
Potentially a higher dose would elicit a response, however a increase in rectal 
temperature was discovered at this dose. Another possible explanation is the many 
glycosylations of AGP may cause the protein to react differently. The increase in rectal 




not record body temperature. High amounts of leptin can cause an increase in body 
temperature, therefore, although not expected, it can be understood. 
In the second experiment, we hypothesized peripheral AGP would affect feed 
intake and body temperature in sheep. Using 10 times the highest dose given in 
experiment one, there was no effect on feed intake or rectal temperature. It may be that 
the AGP concentrations, in plasma, during an inflammatory response are much higher 
then what was given. Potentially a greater dose is needed peripherally since the dose 
administered by this route did not induce a fever. 
In the third experiment, flunixin meglumine, a cyclo-oxygenase inhibitor was 
administered peripherally 30 minutes prior to central AGP. The administration of 
peripheral flunixin meglumine had no effect on the temperature rise via central AGP. 
There was once again a rise in temperature such that ewes treated centrally with AGP had 
greater rectal temperatures at 2, 4, 6, 8, and 12 hours relative to ewes treated centrally 
with saline. These results suggest AGP using a mechanism(s) independent of the 
prostaglandin pathway to increase temperature. 
Alpha-1-acid glycoprotein could be a potential marker for inflammatory or 
infectious disease in ruminants. Although AGP did not reduce feed intake in these 
models, the induction of a rectal temperature was discovered. The temperature is not 
induced through the prostaglandin pathway and future research could focus on the 
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Figure 1. Effects of central α-1-acid-glycoprotein (AGP) administration on feed intake 
rate (kg / hour) in sheep (+/- SEM). Ewes were treated with 1 of 4 treatments [0 (control; 
n = 4), 0.012 (low; n = 4), 0.060 (medium; n = 4), or 0.30 (high; n = 4) mg / kg BW 
AGP] administered in 500 µL of sterile, nonpyrogenic, isotonic, 0.9% sodium chloride 
into the lateral ventricle at time 0 hrs to yield four possible treatment groups. The study 
was repeated until all sheep received all treatments with a 10-day washout period 
between treatments. There was an effect of time (P < 0.0001) and no effect of treatment 
(P = 0.37), or treatment x time interaction (P = 0.97) on feed intake rate. CON, control; 






Figure 2. Effects of central α-1-acid-glycoprotein (AGP) administration on cumulative 
feed intake (kg) in sheep (+/- SEM). Ewes were treated with 1 of 4 treatments [0 (control; 
n = 4), 0.012 (low; n = 4), 0.060 (medium; n = 4), or 0.30 (high; n = 4) mg / kg BW 
AGP] administered in 500 µL of sterile, nonpyrogenic, isotonic, 0.9% sodium chloride 
into the lateral ventricle at time 0 hrs to yield four possible treatment groups. The study 
was repeated until all sheep received all treatments with a 10-day washout period 
between treatments. There was no effect of treatment (P = 0.31) on 48 hour cumulative 






Figure 3. Effects of central α-1-acid-glycoprotein (AGP) administration on rectal 
temperatures (°C) in sheep (+/- SEM). Ewes were treated with 1 of 4 treatments [0 
(control; n = 4), 0.012 (low; n = 4), 0.060 (medium; n = 4), or 0.30 (high; n = 4) mg / kg 
BW AGP] administered in 500 µL of sterile, nonpyrogenic, isotonic, 0.9% sodium 
chloride into the lateral ventricle at time 0 hrs to yield four possible treatment groups. 
The study was repeated until all sheep received all treatments with a 10-day washout 
period between treatments. There was a tendency for an interaction of treatment and time 
(P = 0.07), and there was an effect of time (P < 0.0001) and treatment (P = 0.002) on 
rectal temperature. Rectal temperatures were greater (P < 0.05) with high dose compared 






Figure 4. Effects of peripheral α-1-acid-glycoprotein (AGP) administration on feed intake 
rate (kg / hour) in sheep (+/- SEM). Ewes were treated with one of two treatments [0 
(control; n = 5) and 3.0 (AGP; n = 5) mg / kg BW of AGP] infused via IV catheters at 
time 0 hrs to yield two possible treatment groups. The dose of AGP was selected based 
on the greatest dose administered centrally in experiment one (0.30 mg / kg BW). There 
was no effect of IV treatment (P = 0.98) or treatment x time interaction (P = 0.77), but 






Figure 5. Effects of peripheral α-1-acid-glycoprotein (AGP) administration on cumulative 
feed intake (kg) in sheep (+/- SEM). Ewes were treated with one of two treatments [0 
(control; n = 5) and 3.0 (AGP; n = 5) mg / kg BW of AGP] infused via IV catheters at 
time 0 hrs to yield two possible treatment groups. The dose of AGP was selected based 
on the greatest dose administered centrally in experiment one (0.30 mg / kg BW). There 







Figure 6. Effects of peripheral α-1-acid-glycoprotein (AGP) administration on rectal 
temperatures (°C) in sheep (+/- SEM). Ewes were treated with one of two treatments [0 
(control; n = 5) and 3.0 (AGP; n = 5) mg / kg BW of AGP] infused via IV catheters at 
time 0 hrs to yield two possible treatment groups. The dose of AGP was selected based 
on the greatest dose administered centrally in experiment one (0.30 mg / kg BW). There 
was no effect of treatment (P = 0.71), time (P = 0.10), or treatment x time interaction (P = 






Figure 7. Effects of central α-1-acid-glycoprotein (AGP) and peripheral flunixin 
meglumine (FLU) administration on feed intake rate (kg / hour) in sheep (+/- SEM). 
Ewes were treated with peripheral treatments [administered IV; 0 (control) or 2.2 mg / kg 
BWFLU] 30 minutes prior to receiving centrally [administered ICV through a port and 
catheter into the lateral ventricle of the brain; 0 (control) or 25 mg AGP (approximately 
0.30 mg / kg BW) to yield four possible treatment combinations (CON / CON, n=4; FLU 
/ CON,  n=5; CON / AGP, n =5; FLU / AGP, n=5). There was no effect of central 
treatment administration (P = 0.18), time (P = 0.28) or central treatment by time 
interaction (P = 0.64) on feed intake rate. Moreover, there was no effect of intravenous 
treatment (P = 0.88), intravenous treatment by time interaction (P = 0.21), intravenous by 
central treatment (P = 0.42), or intravenous by central treatment by time interaction (P= 






Figure 8. Effects of central α-1-acid-glycoprotein (AGP) and peripheral flunixin 
meglumine (FLU) administration on cumulative feed intake (kg) in sheep (+/- SEM). 
Ewes were treated with peripheral treatments [administered IV; 0 (control) or 2.2 mg / kg 
BWFLU] 30 minutes prior to receiving centrally [administered ICV through a port and 
catheter into the lateral ventricle of the brain; 0 (control) or 25 mg AGP (approximately 
0.30 mg / kg BW) to yield four possible treatment combinations (CON / CON, n=4; FLU 
/ CON,  n=5; CON / AGP, n =5; FLU / AGP, n=5). There was no effect of central 
treatment (P = 0.79), intravenous treatment (P = 0.92) or their interaction (P = 0.32) on 








Figure 9. Effects of central α-1-acid-glycoprotein (AGP) and peripheral flunixin 
meglumine (FLU) administration on rectal temperatures (°C) in sheep (+/- SEM). Ewes 
were treated with peripheral treatments [administered IV; 0 (control) or 2.2 mg / kg 
BWFLU] 30 minutes prior to receiving centrally [administered ICV through a port and 
catheter into the lateral ventricle of the brain; 0 (control) or 25 mg AGP (approximately 
0.30 mg / kg BW) to yield four possible treatment combinations (CON / CON, n=4; FLU 
/ CON,  n=5; CON / AGP, n =5; FLU / AGP, n=5). There was an effect of central 
treatment administration (P < 0.0001), time (P < 0.0001) and central treatment by time 
interaction (P < 0.0001) on rectal temperature such that ewes treated centrally with AGP 
had greater rectal temperatures at 2, 4, 6, 8, and 12 h relative to ewes treated centrally 
with control. There was no effect of intravenous treatment (P = 0.93), intravenous 
treatment by time interaction (P = 0.35), intravenous by central treatment (P = 0.54), or 




indicates time points at which AGP treated ewes differed from CON treated ewes (P < 









































Table 1. Feed ration composition (DM) of sheep 
Ingredient % 
 Cotton seed hulls 25.00 
 Molasses 7.00 
 Cracked corn 56.00 
 Soybean meal 10.00 
 Calcium phosphate 0.20 
 Limestone calcium 1.00 
 Ade premix 0.10 
 TM salt 0.50 
 Dynamate 0.20 
Nutrient composition  
 Dry matter, % 
89.7 
 CP, % 
11.7 
 ADF, % 
24.30 







Table # 1. Continued 
Ingredient % 
 TDN, % 75.00 
 Calcium, % 0.74 
 Phosphorus, % 0.37 
 Potassium, % 1.08 
 Magnesium, % 0.23 
 Sodium, % 0.26 
 Sulfur, % 0.25 
 Aluminum, mg/kg 132.00 
 Cobalt, mg/kg <0.20 
 Copper, mg/kg 5.06 
 Iron, mg/kg 157.00 
 Magnesium, mg/kg 18.70 
 Molybdenum, mg/kg 1.22 
 Zinc, mg/kg 30.70 





Brittany Antone (Gregg) Tipton was born on April 12, 1990 in Greeneville, TN. 
Brittany graduated from South Greene High School in 2008 and continued her education 
at Hiwassee College in Madisonville, TN. There, she pursued a Bachelor’s of Art degree 
in Equine Management and Training. She then went on to University of Tennessee for a 
Bachelor’s of Science degree in Animal Science and graduated in 2017. In Fall 2017, 
Brittany began studying for her Master of Science under the direction of Dr. Brian 
Whitlock and focusing her research on feed intake and inflammation of transition dairy 
cattle as it relates to an acute phase protein, alpha-1-acid glycoprotein.  
